Analysis of chronic myelogenous leukemia in an underserved, inner-city cohort shows a significant five year overall survival that is not affected by choice of tyrosine kinase inhibitor.
第一作者:
Amer,Assal
第一单位:
a Department of Oncology , Montefiore Medical Center/Albert Einstein College of Medicine , Bronx , NY , USA.
作者:
医学主题词
青少年(Adolescent);成年人(Adult);老年人(Aged);老年人, 80以上(Aged, 80 and over);儿童(Child);选择行为(Choice Behavior);城市(Cities);女(雌)性(Female);卫生服务易得程度(Health Services Accessibility);人类(Humans);白血病, 髓系, 慢性, BCR-ABL阳性(Leukemia, Myelogenous, Chronic, BCR-ABL Positive);男(雄)性(Male);缺医地区(Medically Underserved Area);中年人(Middle Aged);蛋白激酶抑制剂(Protein Kinase Inhibitors);蛋白酪氨酸激酶类(Protein-Tyrosine Kinases);存活率分析(Survival Analysis);市区人口(Urban Population);易伤人群(Vulnerable Populations);青年人(Young Adult)
DOI
10.3109/10428194.2016.1142087
PMID
26886689
发布时间
2019-01-16
- 浏览3
Leukemia & lymphoma
2452-5页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



